Illumina Inc

Abierto

SectorSanidad

176.49 -0.04

Resumen

Variación precio

24h

Actual

Mínimo

174.36

Máximo

181.4

Métricas clave

By Trading Economics

Ingresos

-200M

134M

Ventas

-68M

1.1B

P/B

Media del Sector

29.342

50.958

BPA

1.15

Margen de beneficios

12.282

Empleados

8,600

EBITDA

-219M

226M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 Meses

-14.8% downside

Dividendos

By Acuity

Próximas Ganancias

30 jul 2026

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

4.9B

24B

Apertura anterior

176.53

Cierre anterior

176.49

Noticias sobre sentimiento de mercado

By Acuity

34%

66%

84 / 342 Clasificación en Healthcare

Illumina Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

25 jun 2026, 23:26 UTC

Illumina Inc shares are higher in after-market trading, reflecting strong performance above their 20-day moving average despite no specific news driving the move.

24 jun 2026, 20:02 UTC

News
Social Media

Illumina Inc. shares are higher amid gains in the Life Sciences Tools & Services sector. Barclays raised its price target to $145 from $122.

23 jun 2026, 22:46 UTC

Illumina Inc shares are higher in after-market trading, reflecting a notable advance since Tuesday's close and strong performance near the upper end of its one-month range.

22 jun 2026, 19:32 UTC

Illumina Inc's shares are higher today, despite declines in the Nasdaq. The stock remains flat since Thursday, with no specific news driving the movement.

19 jun 2026, 00:02 UTC

Correlated Moves

Illumina Inc shares are lower in after-market hours, reflecting broader market sentiment as the Russell 2000 Index also declined slightly.

18 jun 2026, 23:01 UTC

Illumina Inc shares are lower in after-market hours following earlier gains. The stock showed unusual volatility during this session without identifiable news.

17 jun 2026, 20:03 UTC

Correlated Moves
Macro Event

Illumina Inc shares are lower today, driven by broader market declines and macroeconomic concerns related to the Federal Reserve's monetary policy decisions.

16 jun 2026, 19:56 UTC

Correlated Moves

Illumina Inc. shares are lower today, following a broader market decline. The stock remains above its 20-day moving average despite recent fluctuations.

15 jun 2026, 13:02 UTC

Correlated Moves

Illumina Inc shares are higher in pre-market trading, reflecting strong momentum since Friday's close and aligning with the broader Russell 2000 Index trend.

12 jun 2026, 19:56 UTC

Illumina Inc's shares are lower today, continuing a downward trend since Thursday. The stock remains above its 20-day moving average despite the decline.

11 jun 2026, 20:03 UTC

Correlated Moves
News

Illumina Inc launched its StrataMap Spatial Solution, enhancing gene detection capabilities. Shares are advancing in Thursday's session, recovering from earlier lows.

10 jun 2026, 23:11 UTC

Illumina Inc shares are higher in after-market trading, supported by a notable upward trend in the Life Sciences Tools & Services sub-sector.

9 jun 2026, 19:26 UTC

News

Illumina shares are advancing, supported by a consensus "Hold" rating from analysts and an average price target of $138.38.

8 jun 2026, 20:06 UTC

News

Illumina Inc launched the StrataMap Spatial Solution, yet shares are declining amid broader market sentiment and sector challenges.

5 jun 2026, 23:16 UTC

Correlated Moves

Illumina Inc shares are roughly flat in after-market trading, reflecting broader market dynamics amid a slight decline in the Russell 2000 Index.

4 jun 2026, 19:51 UTC

Illumina Inc shares are lower today, breaking a trend of higher closes since Wednesday. No specific news was identified to explain this decline.

3 jun 2026, 23:03 UTC

Illumina Inc shares are higher in after-market trading, maintaining levels above its 20-day moving average amid broader market concerns about inflation and geopolitical tensions.

2 jun 2026, 23:21 UTC

Correlated Moves

Illumina Inc shares declined in after-market trading, reflecting broader market trends amid mixed economic signals and a stronger-than-expected JOLTS job openings report.

1 jun 2026, 23:46 UTC

Illumina Inc shares are higher in after-market trading following a report showing U.S. manufacturing activity expanded for the fifth consecutive month.

29 may 2026, 20:03 UTC

Illumina Inc is higher in Friday's session, maintaining gains since Thursday's close. No specific news was identified to explain the price action.

28 may 2026, 23:26 UTC

Illumina Inc shares are higher in after-market hours, reflecting routine trading activity. No specific news has been identified to explain the movement.

27 may 2026, 20:02 UTC

Illumina Inc is trading higher, maintaining strong momentum and peaking during Wednesday's session, despite no specific company news identified for the movement.

21 may 2026, 19:42 UTC

Illumina Inc's shares are higher during Thursday's session, recovering from an earlier dip and trading near the upper end of their one-month range.

20 may 2026, 19:56 UTC

News

Illumina Inc's stock is lower after Yahoo Finance's analysis cites weak revenue growth and concerns over its business quality. Shares rebounded earlier in the session.

19 may 2026, 20:03 UTC

Illumina Inc's shares are higher, supported by gains in the Life Sciences Tools & Services sub-sector, despite midday fluctuations.

18 may 2026, 19:15 UTC

Correlated Moves

Illumina Inc shares are lower, continuing a four-session decline amid rising Treasury yields and broader market trends, including a drop in the Russell 2000 Index.

15 may 2026, 23:56 UTC

Illumina Inc shares are lower in after-market hours, following a decline during the session amid broader market volatility and rising initial jobless claims.

14 may 2026, 23:26 UTC

News

RBC Capital initiated coverage on Illumina Inc with an Outperform rating and a $170 price target. Shares are higher in after-market trading.

13 may 2026, 23:21 UTC

Illumina Inc's shares are higher in after-market trading, maintaining strength above its 20-day moving average and near the top of its one-month range.

Comparación entre iguales

Cambio de precio

Illumina Inc previsión

Precio Objetivo

By TipRanks

-14.8% descenso

Estimación a 12 Meses

Media 149.17 USD  -14.8%

Máximo 185 USD

Mínimo 95 USD

De acuerdo con 12 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Illumina Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

12 ratings

7

Comprar

2

Mantener

3

Vender

Sentimiento

By Acuity

84 / 342 Clasificación en Sanidad

Noticias sobre sentimiento de mercado

Coyuntura alcista

Volatilidad

Por debajo de la media

Volumen de Noticias (RCV)

Por debajo de la media

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Illumina Inc

Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.